...
首页> 外文期刊>Investigational New Drugs >The combination of gamma ionizing radiation and 8-Cl-cAMP induces synergistic cell growth inhibition and induction of apoptosis in human prostate cancer cells
【24h】

The combination of gamma ionizing radiation and 8-Cl-cAMP induces synergistic cell growth inhibition and induction of apoptosis in human prostate cancer cells

机译:γ电离辐射和8-Cl-cAMP的组合诱导人前列腺癌细胞的协同细胞生长抑制和凋亡诱导

获取原文
获取原文并翻译 | 示例
           

摘要

The antiproliferative and cytotoxic potential of the nucleotide analog 8-Cl-cAMP was tested in PC-3 and DU145 metastatic human prostate cancer cells. The drug was examined as the only therapeutic agent and in combination with ionizing irradiation (IR). Highly synergistic effects of IR and 8-Cl-cAMP were observed in both cell lines when examined by the MTT viability and BrdU proliferation assays. The combination of IR and 8-Cl-cAMP at clinically relevant doses exerted substantial growth inhibition. The combination of IR and 8-Cl-cAMP caused a significant disturbance in the distribution of cell cycle phases. Cell cycle arrest in the sub-G0/G1 phase predominated in both cell lines. The most striking observation was a significant increase in apoptotic PC-3 and DU145 cells. The DU145 cells were three times more sensitive to the combined treatment than PC-3 cells. The initial resistance to IR-induced apoptosis in these p53-deficient prostate cancer cell lines was overcome through an alternative proapoptotic pathway induced by 8-Cl-cAMP. Considering the low effective doses of treatments, improved tumor eradication rates and minimal undesirable side effects, the combination of IR and 8-Cl-cAMP could be the therapy of choice in treating prostate cancer.
机译:在PC-3和DU145转移性人前列腺癌细胞中测试了核苷酸类似物8-Cl-cAMP的抗增殖和细胞毒性潜力。该药物被视为唯一的治疗剂,并与电离辐射(IR)结合使用。当通过MTT活力和BrdU增殖测定法检查时,在两种细胞系中观察到IR和8-Cl-cAMP的高度协同作用。 IR和8-Cl-cAMP在临床上相关剂量的组合发挥了显着的生长抑制作用。 IR和8-Cl-cAMP的组合在细胞周期阶段的分布中引起了显着的干扰。在两种细胞系中,亚周期G0 / G1期的细胞周期停滞。最惊人的发现是凋亡的PC-3和DU145细胞显着增加。 DU145细胞对联合治疗的敏感性是PC-3细胞的三倍。在这些p53缺陷的前列腺癌细胞系中,对IR诱导的细胞凋亡的初始抗性通过8-Cl-cAMP诱导的替代促凋亡途径得以克服。考虑到治疗的低有效剂量,改善的肿瘤根除率和最小的不良副作用,IR和8-Cl-cAMP的组合可能是治疗前列腺癌的首选疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号